STERIS plc (STE) stock
STENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 19/300% above fair value
$259.57+2.16 (+0.84%)
Close on Nov 18, 2026Market cap $25.31BP/E 31.7Yield 0.95%
Steris free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Steris's free cash flow for the twelve months ending Jun 30, 2026 was $925.60M, up 1.8% year over year. For fiscal 2026 it was $972.40M, up 25.0% from the year before. The highest annual figure on record is $972.40M in fiscal 2026.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $972.40M | +25.0% |
| FY2025 | Mar 31, 2025 | $778.00M | +26.9% |
| FY2024 | Mar 31, 2024 | $613.00M | +55.2% |
| FY2023 | Mar 31, 2023 | $394.98M | -0.6% |
| FY2022 | Mar 31, 2022 | $397.25M | -11.8% |
| FY2021 | Mar 31, 2021 | $450.38M | +19.8% |
| FY2020 | Mar 31, 2020 | $376.04M | +7.5% |
| FY2019 | Mar 31, 2019 | $349.79M | +19.7% |
| FY2018 | Mar 31, 2018 | $292.18M | +16.3% |
| FY2017 | Mar 31, 2017 | $251.19M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $279.60M | -14.3% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $245.20M | +29.1% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $199.50M | -18.1% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $201.30M | +35.2% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $326.40M | +66.9% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $189.90M | +16.2% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $243.60M | +41.4% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $148.90M | +137.1% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $195.60M | -8.8% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $163.36M | +13.2% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $172.31M | +51.5% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $62.80M | +198.3% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $214.53M | +85.2% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $144.35M | +46.3% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $113.76M | -30.3% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $21.06M | -77.7% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $115.81M | +182.3% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $98.66M | -12.8% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $163.19M | +7.4% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $94.37M | -20.1% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $41.03M | -39.0% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $113.09M | -18.3% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $151.96M | +100.4% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $118.07M | +15.4% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $67.26M | +13.0% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $138.37M | +35.1% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $75.85M | -8.8% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $102.29M | +12.3% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $59.54M | -18.5% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $102.45M | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $83.19M | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $91.10M | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $73.05M | – |
See a number that looks wrong?